SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Davis who wrote (90)5/16/1999 9:38:00 PM
From: moat   of 315
 
Bob, First, thank you for your web site and its excellent reporting & analysis.

Besides you and BlueStone's Scott Baily, who else knows CLZR well and its product space?

Here is how I see the situation. Because of the nice product cycle that started 3 quarter ago, CLZR is showing strong Q/Q growth, hence its EPS is heading north. Question: should we be concerned with the competition since product cycles are pretty short in this space? Who's coming up next to eat CLZR's lunch?

(Is Palomar down because of CLZR -- due better, newer, and cheaper products?)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News